Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeJohnson & JohnsonStark & Stark Wins $20 Million Verdict Against Johnson & Johnson

Stark & Stark Wins $20 Million Verdict Against Johnson & Johnson


PA jury court awards NJ woman in pelvic mesh implant case

Stark & Stark, a law practice based here, announced that a Pennsylvania state jury has awarded a New Jersey woman a $20 million verdict for injuries she suffered after receiving a pelvic mesh implant made by Ethicon, a subsidiary of Johnson & Johnson.

Peggy Engleman of Cinnaminson, NJ, was awarded $2.5 million compensatory damages and $17.5 million in punitive damages, following a three-week trial in Philadelphia Common Pleas Court. Stark & Stark filed the complaint for Ms. Engleman and co-counseled with other firms to prosecute the case.

Originally filed by Stark & Stark in 2013, the suit claimed that a TVT-Secur device manufactured by Ethicon, a subsidiary of Johnson & Johnson, was defective and that the companies failed to warn users of the risks. Ms. Engleman had the device implanted in 2007 to relieve stress urinary incontinence, but said the device failed within a month and her condition returned.  She began to experience pain and discomfort as the mesh started to erode inside her body and had multiple surgeries as a result. However, physicians were unable to remove all the shards of mesh in her abdomen.

The pelvic mesh litigation still has 183 cases pending, with the next one scheduled to go on trial May 22. Two earlier pelvic-mesh verdicts in Philadelphia against Johnson & Johnson/Ethicon resulted in awards of $12.5 million and $13.5 million. Johnson & Johnson also faces tens of thousands of additional lawsuits around the country regarding pelvic mesh implants.

Martin P. Schrama and Stefanie Colella-Walsh, both partners with Stark & Stark, filed the complaint of behalf of Peggy Engleman and worked with a team of attorneys on the case.

“Through this stunning verdict, the jury has unequivocally shown that Johnson & Johnson will have to pay a high price if their products are defective and harmful as well as their marketing practices unethical,” said Mr. Schrama.

Ms. Colella-Walsh added, “We are proud to bring justice for Peggy Engleman, who suffered incredible anguish and suffering, and hope to win additional verdicts for others experiencing unexpected consequences as a result of pelvic mesh implant failure.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy